Test BankFor Basic & Applied Concepts of BloodBankingand T
qq qq qq qq qq qq qq qq qq qq qq
Practices 5th Edition – ByPaula Howard
qq qq qq qq qq qq
|Verified Chapter's 1 -16 | Complete
qq qq qq qq qq qq qq
,Table of Contents qq qq
Part I: QualityandSafety Issues
qq qq qq q qq
1. Quality Assurance and Regulation of the Blood Industry: Safety Issues in the Blood Bank…………
qq qq q qq q qq q qq qq qq q qq q
Foundations:BasicSciencesandReagents
qq qq qq qq q
2. Immunology:BasicPrinciplesandApplicationsintheBloodBank…………………………………………………….8 q q q q q q q q q
3. BloodBankingReagents:OverviewandApplications……………………………………………………………………13
q q q q q
BloodBanking……………………………………………………………………………………….18
q q q q Part III:Overview ofthe
qq qq qq qq
5. ABO and H Blood Group Systems and Secretor Status………………………………………………………………….2
q q q q q q q q q
System……………………………………………………………………………………………………26
q
7. OtherRedCellBloodGroupSystems,HumanLeukocyteAntigens,andPlateletAntigens………………………
q q q q q qq q qq q q qq
EssentialsofPretransfusionTesting
qq qq q q
8. Antibody Detection and Identification……………………………………………………………………………………34
qq qq q q qq qq q q qq qq q q q
q q Testing………………………………………………………………………………………………………38
10. Blood Bank Automation for Transfusion Services……………………………………………………………………
q q q q q
ConsiderationsinImmunohematology
q qq q
11. AdverseComplicationsofTransfusions………………………………………………………………………………….46
q q q
12. Hemolytic Disease of the Fetus and Newborn………………………………………………………………………… q q q q q q
CollectingandTesting
q qq q
13. Donor Selection and Phlebotomy………………………………………………………………………………………….55
q q q q
Blood…………………………………………………………………………………………………….60
q q q Part VII: Blood Comp
qq qq q
TransfusionTherapy
q q
15. BloodComponentPreparationandTherapy…………………………………………………………………………….63
q q q q
16. TransfusionTherapyinSelectedPatients………………………………………………………………………………..66 q q q q q
,Chapter 01: QualityAssurance andRegulation ofthe BloodIndustry andSafety Issues inthe BloodBank
qq qq qq qq q qq q qq q qq q qq qq q qq q q
AppliedConcepts ofBloodBanking andTransfusionPractices, 5thEdition
qq q qq q q qq q qq qq q
MULTIPLE CHOICE qq
1. Biosafety levels determine: qq qq
a. on what floor certain infectious disease testing can be performed.
qq qq qq qq qq qq qq qq qq
b. the degree of risk for certain areas ofa health care facilityto exposure to
qq qq qq qq qq qq qq qq qq qq qq qq qq qq
qinfectious diseases.
q qq
c. the amount of ventilation required in a transfusion service.
qq qq qq qq qq qq qq qq
d. how many biohazardous waste containers a laboratory must have.
qq qq qq qq qq qq qq qq
ANS: B q q
OSHA defines biosafety levels based on potential exposure to infectious material.
qq qq qq qq qq qq qq qq qq qq
DIF: Level 1 qq
2. A laboratorytechnologist decided she would like to bring her lab coat home for laundering because it had
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
it was returned bythe laboratory’s laundry service. Is this practice acceptable?
qq qq qq qq qq qq qq q q qq qq qq
a. Yes, if she uses 10% bleach qq qq qq qq qq
b. Yes, if she clears it with her supervisor qq qq qq qq qq qq qq
c. Yes, as long as she removes the coat and does not wear it home qq qq qq qq qq qq qq qq qq qq qq qq qq
d. No, because the laboratory is a biosafety level2, and lab coats may not be
qq qq qq qq qq qq qq qq qq qq qq qq qq qq
removed q q
ANS: D q q
Methods of transporting the lab coat and the risk of contamination do not permit health care workers to br
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
qcleaning.
q
DIF: Level 2 qq
3. Personalprotective equipment includes: qq qq qq
a. safetyglasses. qq
b. splash barriers. qq
c. masks.
d. Allof the above qq qq qq
ANS: D q q
Safetyglasses, splash barriers, and masks are types of personalprotective devices.
qq qq qq qq qq qq qq qq qq qq qq
DIF: Level 1 qq
4. At what point in the employment process should safetytraining take place?
qq qq qq qq qq qq qq qq qq qq qq
a. During orientation and training qq qq qq
b. Following lab training when employees are more familiar with their qq qq qq qq qq qq qq qq qq
qresponsibilities
q
c. Following the employees’ first evaluation qq qq qq qq
d. Before independent work is permitted and annuallythereafter qq qq qq qq qq qq qq
ANS: D q q
The Occupation Safetyand Health Administration requires safetytraining before independent work is perm
qq qq qq qq qq qq qq qq qq qq qq qq qq
q thereafter.
q
DIF: Level 1 qq
, 7. Which of the following is true regarding good manufacturing practices (GMPs)?
qq qq qq qq qq qq qq qq qq qq
a. GMPs are legalrequirements established by the Food and Drug Administration. qq qq qq qq qq qq qq qq qq qq
b. GMPs are optionalguidelines written by the AABB. qq qq qq qq qq qq qq
c. GMPs are required only by pharmaceutical companies. qq qq qq qq qq qq
d. GMPs are part of the qualitycontrolrequirements for blood products. qq qq qq qq qq qq qq qq qq qq
ANS: A q q
Good manufacturing practices are requirements established by the Food and Drug Administration.
qq qq qq qq qq qq qq qq qq qq qq
DIF: Level 1 qq
8. Which of the following is an example of an unacceptable record-keeping procedure?
qq qq qq q q qq qq qq qq qq qq qq
a. Using dittos in columns to save time qq qq qq qq qq qq
b. Recording the date and initials next to a correction qq qq qq qq qq qq qq qq
c. Not deleting the original entrywhen making a correction qq qq qq qq qq qq qq qq
d. Always using permanent ink on all records qq qq qq qq qq qq
ANS: A q q
Allrecords must be clearly written. Dittos are unacceptable.
qq qq qq qq qq qq qq qq
DIF: Level 1 qq
9. A technologist in training noticed that the person training her had not recordedthe results of a test. To be h
qq qq qq q q qq qq qq qq qq qq qq q q qq qq qq qq qq qq qq qq
q q recordedthe results she saw at a later time, using the technologist’s initials. Is this an acceptable proced
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
a. Yes; allresults must be recorded regardless of who did the test.
qq qq qq qq qq qq qq qq qq qq qq
b. No; she should have brought the error to the technologist’s attention.
qq qq qq qq qq qq qq qq qq qq
c. Yes; because she used the other technologist’s initials.qq qq qq qq qq qq qq
d. Yes; as long as she records the result in pencil. qq qq qq qq qq qq qq qq qq
ANS: B q q
This is an example of poor record keeping; results must be recorded when the test is performed and bythe
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
DIF: Level 3 qq
10. Unacceptable quality controlresults for the antiglobulin test performed in test tubes may be noticed if: qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
a. preventive maintenance has not been performed onthe cell washer. qq qq qq qq qq qq qq qq qq
b. the technologist performing the test was never trained.
qq qq qq qq qq qq qq
c. the reagents used were improperlystored. qq qq qq qq qq
d. Allof the above qq qq qq
ANS: D q q
Training, equipment maintenance, and reagent qualitycan affect quality control.
qq q q qq qq qq qq qq qq qq
DIF: Level 2 qq
11. Allof the following are true regarding competency testing except:
qq qq qq qq qq qq qq qq q q
a. it must be performed following training.
q q qq qq qq qq
b. it must be performed on an annual basis.
q q qq qq qq qq qq qq
c. it is required only ifthe technologist has no experience.
q q qq qq qq qq qq qq qq qq
d. retraining is required if there is a failure in competency testing. qq qq qq qq qq qq qq qq qq qq
ANS: C q q
All employees must have competencytesting following training and annually thereafter. Ifthere is a failure
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
q retraining is required.
q qq qq
DIF: Level 2 qq
12. Which of the following organizations are involved in the regulation of blood banks?
qq qq qq qq qq qq qq qq qq qq qq qq
qq qq qq qq qq qq qq qq qq qq qq
Practices 5th Edition – ByPaula Howard
qq qq qq qq qq qq
|Verified Chapter's 1 -16 | Complete
qq qq qq qq qq qq qq
,Table of Contents qq qq
Part I: QualityandSafety Issues
qq qq qq q qq
1. Quality Assurance and Regulation of the Blood Industry: Safety Issues in the Blood Bank…………
qq qq q qq q qq q qq qq qq q qq q
Foundations:BasicSciencesandReagents
qq qq qq qq q
2. Immunology:BasicPrinciplesandApplicationsintheBloodBank…………………………………………………….8 q q q q q q q q q
3. BloodBankingReagents:OverviewandApplications……………………………………………………………………13
q q q q q
BloodBanking……………………………………………………………………………………….18
q q q q Part III:Overview ofthe
qq qq qq qq
5. ABO and H Blood Group Systems and Secretor Status………………………………………………………………….2
q q q q q q q q q
System……………………………………………………………………………………………………26
q
7. OtherRedCellBloodGroupSystems,HumanLeukocyteAntigens,andPlateletAntigens………………………
q q q q q qq q qq q q qq
EssentialsofPretransfusionTesting
qq qq q q
8. Antibody Detection and Identification……………………………………………………………………………………34
qq qq q q qq qq q q qq qq q q q
q q Testing………………………………………………………………………………………………………38
10. Blood Bank Automation for Transfusion Services……………………………………………………………………
q q q q q
ConsiderationsinImmunohematology
q qq q
11. AdverseComplicationsofTransfusions………………………………………………………………………………….46
q q q
12. Hemolytic Disease of the Fetus and Newborn………………………………………………………………………… q q q q q q
CollectingandTesting
q qq q
13. Donor Selection and Phlebotomy………………………………………………………………………………………….55
q q q q
Blood…………………………………………………………………………………………………….60
q q q Part VII: Blood Comp
qq qq q
TransfusionTherapy
q q
15. BloodComponentPreparationandTherapy…………………………………………………………………………….63
q q q q
16. TransfusionTherapyinSelectedPatients………………………………………………………………………………..66 q q q q q
,Chapter 01: QualityAssurance andRegulation ofthe BloodIndustry andSafety Issues inthe BloodBank
qq qq qq qq q qq q qq q qq q qq qq q qq q q
AppliedConcepts ofBloodBanking andTransfusionPractices, 5thEdition
qq q qq q q qq q qq qq q
MULTIPLE CHOICE qq
1. Biosafety levels determine: qq qq
a. on what floor certain infectious disease testing can be performed.
qq qq qq qq qq qq qq qq qq
b. the degree of risk for certain areas ofa health care facilityto exposure to
qq qq qq qq qq qq qq qq qq qq qq qq qq qq
qinfectious diseases.
q qq
c. the amount of ventilation required in a transfusion service.
qq qq qq qq qq qq qq qq
d. how many biohazardous waste containers a laboratory must have.
qq qq qq qq qq qq qq qq
ANS: B q q
OSHA defines biosafety levels based on potential exposure to infectious material.
qq qq qq qq qq qq qq qq qq qq
DIF: Level 1 qq
2. A laboratorytechnologist decided she would like to bring her lab coat home for laundering because it had
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
it was returned bythe laboratory’s laundry service. Is this practice acceptable?
qq qq qq qq qq qq qq q q qq qq qq
a. Yes, if she uses 10% bleach qq qq qq qq qq
b. Yes, if she clears it with her supervisor qq qq qq qq qq qq qq
c. Yes, as long as she removes the coat and does not wear it home qq qq qq qq qq qq qq qq qq qq qq qq qq
d. No, because the laboratory is a biosafety level2, and lab coats may not be
qq qq qq qq qq qq qq qq qq qq qq qq qq qq
removed q q
ANS: D q q
Methods of transporting the lab coat and the risk of contamination do not permit health care workers to br
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
qcleaning.
q
DIF: Level 2 qq
3. Personalprotective equipment includes: qq qq qq
a. safetyglasses. qq
b. splash barriers. qq
c. masks.
d. Allof the above qq qq qq
ANS: D q q
Safetyglasses, splash barriers, and masks are types of personalprotective devices.
qq qq qq qq qq qq qq qq qq qq qq
DIF: Level 1 qq
4. At what point in the employment process should safetytraining take place?
qq qq qq qq qq qq qq qq qq qq qq
a. During orientation and training qq qq qq
b. Following lab training when employees are more familiar with their qq qq qq qq qq qq qq qq qq
qresponsibilities
q
c. Following the employees’ first evaluation qq qq qq qq
d. Before independent work is permitted and annuallythereafter qq qq qq qq qq qq qq
ANS: D q q
The Occupation Safetyand Health Administration requires safetytraining before independent work is perm
qq qq qq qq qq qq qq qq qq qq qq qq qq
q thereafter.
q
DIF: Level 1 qq
, 7. Which of the following is true regarding good manufacturing practices (GMPs)?
qq qq qq qq qq qq qq qq qq qq
a. GMPs are legalrequirements established by the Food and Drug Administration. qq qq qq qq qq qq qq qq qq qq
b. GMPs are optionalguidelines written by the AABB. qq qq qq qq qq qq qq
c. GMPs are required only by pharmaceutical companies. qq qq qq qq qq qq
d. GMPs are part of the qualitycontrolrequirements for blood products. qq qq qq qq qq qq qq qq qq qq
ANS: A q q
Good manufacturing practices are requirements established by the Food and Drug Administration.
qq qq qq qq qq qq qq qq qq qq qq
DIF: Level 1 qq
8. Which of the following is an example of an unacceptable record-keeping procedure?
qq qq qq q q qq qq qq qq qq qq qq
a. Using dittos in columns to save time qq qq qq qq qq qq
b. Recording the date and initials next to a correction qq qq qq qq qq qq qq qq
c. Not deleting the original entrywhen making a correction qq qq qq qq qq qq qq qq
d. Always using permanent ink on all records qq qq qq qq qq qq
ANS: A q q
Allrecords must be clearly written. Dittos are unacceptable.
qq qq qq qq qq qq qq qq
DIF: Level 1 qq
9. A technologist in training noticed that the person training her had not recordedthe results of a test. To be h
qq qq qq q q qq qq qq qq qq qq qq q q qq qq qq qq qq qq qq qq
q q recordedthe results she saw at a later time, using the technologist’s initials. Is this an acceptable proced
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
a. Yes; allresults must be recorded regardless of who did the test.
qq qq qq qq qq qq qq qq qq qq qq
b. No; she should have brought the error to the technologist’s attention.
qq qq qq qq qq qq qq qq qq qq
c. Yes; because she used the other technologist’s initials.qq qq qq qq qq qq qq
d. Yes; as long as she records the result in pencil. qq qq qq qq qq qq qq qq qq
ANS: B q q
This is an example of poor record keeping; results must be recorded when the test is performed and bythe
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
DIF: Level 3 qq
10. Unacceptable quality controlresults for the antiglobulin test performed in test tubes may be noticed if: qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
a. preventive maintenance has not been performed onthe cell washer. qq qq qq qq qq qq qq qq qq
b. the technologist performing the test was never trained.
qq qq qq qq qq qq qq
c. the reagents used were improperlystored. qq qq qq qq qq
d. Allof the above qq qq qq
ANS: D q q
Training, equipment maintenance, and reagent qualitycan affect quality control.
qq q q qq qq qq qq qq qq qq
DIF: Level 2 qq
11. Allof the following are true regarding competency testing except:
qq qq qq qq qq qq qq qq q q
a. it must be performed following training.
q q qq qq qq qq
b. it must be performed on an annual basis.
q q qq qq qq qq qq qq
c. it is required only ifthe technologist has no experience.
q q qq qq qq qq qq qq qq qq
d. retraining is required if there is a failure in competency testing. qq qq qq qq qq qq qq qq qq qq
ANS: C q q
All employees must have competencytesting following training and annually thereafter. Ifthere is a failure
qq qq qq qq qq qq qq qq qq qq qq qq qq qq qq
q retraining is required.
q qq qq
DIF: Level 2 qq
12. Which of the following organizations are involved in the regulation of blood banks?
qq qq qq qq qq qq qq qq qq qq qq qq
